Clinical relevance of contextual factors as triggers of placebo and nocebo effects in musculoskeletal pain

Giacomo Rossettini, Elisa Carlino, Marco Testa, Giacomo Rossettini, Elisa Carlino, Marco Testa

Abstract

Placebo and nocebo effects are embodied psycho-neurobiological responses capable of modulating pain and producing changes at different neurobiological, body at perceptual and cognitive levels. These modifications are triggered by different contextual factors (CFs) presented in the therapeutic encounter between patient and healthcare providers, such as healing rituals and signs. The CFs directly impact on the quality of the therapeutic outcome: a positive context, that is a context characterized by the presence of positive CFs, can reduce pain by producing placebo effects, while a negative context, characterized by the presence of negative CFs, can aggravate pain by creating nocebo effects. Despite the increasing interest about this topic; the detailed study of CFs as triggers of placebo and nocebo effects is still lacked in the management of musculoskeletal pain.Increasing evidence suggest a relevant role of CFs in musculoskeletal pain management. CFs are a complex sets of internal, external or relational elements encompassing: patient's expectation, history, baseline characteristics; clinician's behavior, belief, verbal suggestions and therapeutic touch; positive therapeutic encounter, patient-centered approach and social learning; overt therapy, posology of intervention, modality of treatment administration; marketing features of treatment and health care setting. Different explanatory models such as classical conditioning and expectancy can explain how CFs trigger placebo and nocebo effects. CFs act through specific neural networks and neurotransmitters that were described as mediators of placebo and nocebo effects.Available findings suggest a relevant clinical role and impact of CFs. They should be integrated in the clinical reasoning to increase the number of treatment solutions, boosts their efficacy and improve the quality of the decision-making. From a clinical perspective, the mindful manipulation of CFs represents a useful opportunity to enrich a well-established therapy in therapeutic setting within the ethical border. From a translational perspective, there is a strong need of research studies on CFs close to routine and real-world clinical practice in order to underline the uncertainty of therapy action and help clinicians to implement knowledge in daily practice.

Keywords: Clinical reasoning; Conditioning; Contextual factors; Expectation; Learning; Nocebo; Pain; Placebo; Therapeutic encounter; Therapeutic relationship.

Conflict of interest statement

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Psycho-neurobiological mechanism of CFs. The image displays how CFs are capable to influence the brain networks, neurochemistry and therapeutic outcome. The principal neural areas and neurotransmitters involved in placebo and nocebo effects are reported. Abbreviation: rACC = Rostral Anterior Cingulate Cortex; DLPFC = Dorsolateral prefrontal cortex; PAG = Periaqueductal gray
Fig. 2
Fig. 2
Influencers of decision-making process. The image presents: a the clinical situation in which meeting patient’s expectation, previous experience and beliefs creates positive therapeutic outcomes; b the clinical situation in which ignoring patient’s expectation, previous experience and beliefs creates negative therapeutic outcomes
Fig. 3
Fig. 3
Social interaction and learning. The image displays: a a positive social interaction between patients in waiting room capable to produce positive therapeutic outcome; b a negative social interaction between patients in waiting room capable to produce negative therapeutic outcome
Fig. 4
Fig. 4
Therapeutic rituals and overt therapeutic administration. The image displays: a an enrich therapeutic context capable to produce positive therapeutic outcome; b a poor therapeutic context capable to produce negative therapeutic outcome

References

    1. Williams AC, Craig KD. Updating the definition of pain. Pain. 2016;157(11):2420–2423. doi: 10.1097/j.pain.0000000000000613.
    1. Dieppe P. Chronic Musculoskeletal Pain. BMJ. 2013;346:f3146. doi: 10.1136/bmj.f3146.
    1. Woolf AD, Erwin J, March L. The need to address the burden of musculoskeletal conditions. Best Pract Res Clin Rheumatol. 2012;26(2):183–224. doi: 10.1016/j.berh.2012.03.005.
    1. Gerdle B, Ghafouri B, Ernberg M, Larsson B. Chronic musculoskeletal pain: review of mechanisms and biochemical biomarkers as assessed by the microdialysis technique. J Pain Res. 2014;7:313–326. doi: 10.2147/JPR.S59144.
    1. Iannetti GD, Mouraux A. From the neuromatrix to the pain matrix (and back) Exp Brain Res. 2010;205(1):1–12. doi: 10.1007/s00221-010-2340-1.
    1. Pelletier R, Higgins J, Bourbonnais D. Is neuroplasticity in the central nervous system the missing link to our understanding of chronic musculoskeletal disorders? BMC Musculoskelet Disord. 2015;16:25. doi: 10.1186/s12891-015-0480-y.
    1. Blasini M, Corsi N, Klinger R, Colloca L. Nocebo and pain: an overview of the psychoneurobiological mechanisms. PAIN Rep. 2017;2(2):e585. doi: 10.1097/PR9.0000000000000585.
    1. Vase L, Skyt I, Hall KT. Placebo, nocebo, and neuropathic pain. Pain. 2016;157(Suppl 1):S98–105. doi: 10.1097/j.pain.0000000000000445.
    1. Colagiuri B, Schenk LA, Kessler MD, Dorsey SG, Colloca L. The placebo effect: from concepts to genes. Neuroscience. 2015;307:171–190. doi: 10.1016/j.neuroscience.2015.08.017.
    1. Schedlowski M, Enck P, Rief W, Bingel U. Neuro-bio-behavioral mechanisms of placebo and Nocebo responses: implications for clinical trials and clinical practice. Pharmacol Rev. 2015;67(3):697–730. doi: 10.1124/pr.114.009423.
    1. Colloca L, Klinger R, Flor H, Bingel U. Placebo analgesia: psychological and neurobiological mechanisms. Pain. 2013;154(4):511–514. doi: 10.1016/j.pain.2013.02.002.
    1. Colloca L, Enck P, DeGrazia D. Relieving pain using dose-extending placebos: a scoping review. Pain. 2016;157(8):1590–1598. doi: 10.1097/j.pain.0000000000000566.
    1. Belcher AM, Ferre S, Martinez PE, Colloca L. Role of placebo effects in pain and neuropsychiatric disorders. Prog Neuro-Psychopharmacol Biol Psychiatry. 2017;17:30164–30161.
    1. Colloca L, Miller FG. The nocebo effect and its relevance for clinical practice. Psychosom Med. 2011;73(7):598–603. doi: 10.1097/PSY.0b013e3182294a50.
    1. Benedetti F. Placebo effects: from the neurobiological paradigm to translational implications. Neuron. 2014;84(3):623–637. doi: 10.1016/j.neuron.2014.10.023.
    1. Benedetti F, Lanotte M, Lopiano L, Colloca L. When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience. 2007;147(2):260–271. doi: 10.1016/j.neuroscience.2007.02.020.
    1. Di Blasi Z, Harkness E, Ernst E, Georgiou A, Kleijnen J. Influence of context effects on health outcomes: a systematic review. Lancet. 2001;357(9258):757–762. doi: 10.1016/S0140-6736(00)04169-6.
    1. Benedetti F. Placebo and the new physiology of the doctor-patient relationship. Physiol Rev. 2013;93(3):1207–1246. doi: 10.1152/physrev.00043.2012.
    1. Wager TD, Atlas LY. The neuroscience of placebo effects: connecting context, learning and health. Nat Rev Neurosci. 2015;16(7):403–418. doi: 10.1038/nrn3976.
    1. Carlino E, Frisaldi E, Benedetti F. Pain and the context. Nat Rev Rheumatol. 2014;10(6):348–355. doi: 10.1038/nrrheum.2014.17.
    1. Carlino E, Benedetti F. Different contexts, different pains, different experiences. Neuroscience. 2016;338:19–26. doi: 10.1016/j.neuroscience.2016.01.053.
    1. Geuter S, Koban L, Wager TD. The cognitive neuroscience of placebo effects: concepts, predictions, and physiology. Annu Rev Neurosci. 2017;40:167–188. doi: 10.1146/annurev-neuro-072116-031132.
    1. Doering BK, Rief W. Utilizing placebo mechanisms for dose reduction in pharmacotherapy. Trends Pharmacol Sci. 2012;33(3):165–172. doi: 10.1016/j.tips.2011.12.001.
    1. Buchel C, Geuter S, Sprenger C, Eippert F. Placebo analgesia: a predictive coding perspective. Neuron. 2014;81(6):1223–1239. doi: 10.1016/j.neuron.2014.02.042.
    1. Shaibani A, Frisaldi E, Benedetti F. Placebo response in pain, fatigue, and performance: possible implications for neuromuscular disorders. Muscle Nerve. 2017;56(3):358–367. doi: 10.1002/mus.25635.
    1. Schafer SM, Geuter S, Wager TD. Mechanisms of placebo analgesia: a dual-process model informed by insights from cross-species comparisons. Prog Neurobiol. 2018;160:101–122. doi: 10.1016/j.pneurobio.2017.10.008.
    1. Lucassen P, Olesen F. Context as a drug: some consequences of placebo research for primary care. Scand J Prim Health Care. 2016;34(4):428–433. doi: 10.1080/02813432.2016.1249065.
    1. Manchikanti L, Boswell MV, Kaye AD, Helm Ii S, Hirsch JA. Therapeutic role of placebo: evolution of a new paradigm in understanding research and clinical practice. Pain Physician. 2017;20(5):363–386.
    1. Carlino E, Pollo A, Benedetti F. Placebo analgesia and beyond: a melting pot of concepts and ideas for neuroscience. Curr Opin Anaesthesiol. 2011;24(5):540–544. doi: 10.1097/ACO.0b013e328349d0c2.
    1. Geers AL, Miller FG. Understanding and translating the knowledge about placebo effects: the contribution of psychology. Curr Opin Psychiatry. 2014;27(5):326–331. doi: 10.1097/YCO.0000000000000082.
    1. Tracey I. Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans. Nat Med. 2010;16(11):1277–1283. doi: 10.1038/nm.2229.
    1. Benedetti F, Carlino E, Pollo A. How placebos change the patient's brain. Neuropsychopharmacology. 2011;36(1):339–354. doi: 10.1038/npp.2010.81.
    1. Testa M, Rossettini G. Enhance placebo, avoid nocebo: how contextual factors affect physiotherapy outcomes. Man Ther. 2016;24:65–74. doi: 10.1016/j.math.2016.04.006.
    1. Paterson C, Dieppe P. Characteristic and incidental (placebo) effects in complex interventions such as acupuncture. BMJ. 2005;330(7501):1202–1205. doi: 10.1136/bmj.330.7501.1202.
    1. Bishop M, Torres-Cueco R, Gay CW, Lluch-Girbés E, Beneciuk JM, Bialosky JE. What effect can manual therapy have on a patient's pain experience? Pain Manag. 2015;5(6):455–464. doi: 10.2217/pmt.15.39.
    1. Bialosky JE, Bishop MD, Price DD, Robinson ME, George SZ. The mechanisms of manual therapy in the treatment of musculoskeletal pain: a comprehensive model. Man Ther. 2009;14(5):531–538. doi: 10.1016/j.math.2008.09.001.
    1. Bialosky JE, Beneciuk JM, Bishop MD, Coronado RA, Penza CW, Simon CB, George SZ. Unraveling the mechanisms of manual therapy: modeling an approach. J Orthop Sports Phys Ther. 2018;48(1):8–18. doi: 10.2519/jospt.2018.7476.
    1. Dieppe P, Goldingay S, Greville-Harris M. The power and value of placebo and nocebo in painful osteoarthritis. Osteoarthr Cartil. 2016;24(11):1850–1857. doi: 10.1016/j.joca.2016.06.007.
    1. O'Sullivan P, Caneiro JP, O'Keeffe M, O'Sullivan K. Unraveling the complexity of low back pain. J Orthop Sports Phys Ther. 2016;46(11):932–937. doi: 10.2519/jospt.2016.0609.
    1. Balint M. The doctor his patient and the illness. Lancet. 1955;265(6866):683–688. doi: 10.1016/S0140-6736(55)91061-8.
    1. Miller FG, Kaptchuk TJ. The power of context: reconceptualizing the placebo effect. J R Soc Med. 2008;101(5):222–225. doi: 10.1258/jrsm.2008.070466.
    1. Benedetti F, Carlino E, Pollo A. Hidden administration of drugs. Clin Pharmacol Ther. 2011;90(5):651–661. doi: 10.1038/clpt.2011.206.
    1. Colloca L, Lopiano L, Lanotte M, Benedetti F. Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol. 2004;3(11):679–684. doi: 10.1016/S1474-4422(04)00908-1.
    1. Benedetti F, Maggi G, Lopiano L, Lanotte M, Rainero I, Vighetti S, Pollo A: Open versus hidden medical treatments: the patient’s knowledge about a therapy affects the therapy outcome. Prevention Treatment 2003, 6(1):No Pagination Specified.
    1. Benedetti F, Colloca L, Lanotte M, Bergamasco B, Torre E, Lopiano L. Autonomic and emotional responses to open and hidden stimulations of the human subthalamic region. Brain Res Bull. 2004;63(3):203–211. doi: 10.1016/j.brainresbull.2004.01.010.
    1. Amanzio M, Pollo A, Maggi G, Benedetti F. Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain. 2001;90(3):205–215. doi: 10.1016/S0304-3959(00)00486-3.
    1. Horing B, Weimer K, Muth ER, Enck P. Prediction of placebo responses: a systematic review of the literature. Front Psychol. 2014;5:1079. doi: 10.3389/fpsyg.2014.01079.
    1. Benedetti F, Frisaldi E, Carlino E, Giudetti L, Pampallona A, Zibetti M, Lanotte M, Lopiano L. Teaching neurons to respond to placebos. J Physiol. 2016;594(19):5647–5660. doi: 10.1113/JP271322.
    1. Vase L, Amanzio M, Price DD. Nocebo vs. placebo: the challenges of trial design in analgesia research. Clin Pharmacol Ther. 2015;97(2):143–150. doi: 10.1002/cpt.31.
    1. Enck P, Bingel U, Schedlowski M, Rief W. The placebo response in medicine: minimize, maximize or personalize? Nat Rev Drug Discov. 2013;12(3):191–204. doi: 10.1038/nrd3923.
    1. Wickramasekera I. A conditioned response model of the placebo effect predictions from the model. Biofeedback Self Regul. 1980;5(1):5–18. doi: 10.1007/BF00999060.
    1. Kirsch I. Response expectancy as a determinant of experience and behavior. Am Psychol. 1985;40(11):1189–1202. doi: 10.1037/0003-066X.40.11.1189.
    1. Bingel U, Wanigasekera V, Wiech K, Ni Mhuircheartaigh R, Lee MC, Ploner M, Tracey I. The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med. 2011;3(70):70ra14. doi: 10.1126/scitranslmed.3001244.
    1. Colloca L, Miller FG. How placebo responses are formed: a learning perspective. Philos Trans R Soc Lond Ser B Biol Sci. 2011;366(1572):1859–1869. doi: 10.1098/rstb.2010.0398.
    1. Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ, Kosslyn SM, Rose RM, Cohen JD. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science. 2004;303(5661):1162–1167. doi: 10.1126/science.1093065.
    1. Bingel U, Lorenz J, Schoell E, Weiller C, Buchel C. Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain. 2006;120(1-2):8–15. doi: 10.1016/j.pain.2005.08.027.
    1. Eippert F, Bingel U, Schoell ED, Yacubian J, Klinger R, Lorenz J, Buchel C. Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron. 2009;63(4):533–543. doi: 10.1016/j.neuron.2009.07.014.
    1. Lui F, Colloca L, Duzzi D, Anchisi D, Benedetti F, Porro CA. Neural bases of conditioned placebo analgesia. Pain. 2010;151(3):816–824. doi: 10.1016/j.pain.2010.09.021.
    1. Elsenbruch S, Kotsis V, Benson S, Rosenberger C, Reidick D, Schedlowski M, Bingel U, Theysohn N, Forsting M, Gizewski ER. Neural mechanisms mediating the effects of expectation in visceral placebo analgesia: an fMRI study in healthy placebo responders and nonresponders. Pain. 2012;153(2):382–390. doi: 10.1016/j.pain.2011.10.036.
    1. Geuter S, Buchel C. Facilitation of pain in the human spinal cord by nocebo treatment. J Neurosci. 2013;33(34):13784–13790. doi: 10.1523/JNEUROSCI.2191-13.2013.
    1. Petrovic P, Kalso E, Petersson KM, Andersson J, Fransson P, Ingvar M. A prefrontal non-opioid mechanism in placebo analgesia. Pain. 2010;150(1):59–65. doi: 10.1016/j.pain.2010.03.011.
    1. Petrovic P, Kalso E, Petersson KM, Ingvar M. Placebo and opioid analgesia-- imaging a shared neuronal network. Science. 2002;295(5560):1737–1740. doi: 10.1126/science.1067176.
    1. Amanzio M, Benedetti F, Porro CA, Palermo S, Cauda F. Activation likelihood estimation meta-analysis of brain correlates of placebo analgesia in human experimental pain. Hum Brain Mapp. 2013;34(3):738–752.
    1. Sawamoto N, Honda M, Okada T, Hanakawa T, Kanda M, Fukuyama H, Konishi J, Shibasaki H. Expectation of pain enhances responses to nonpainful Somatosensory stimulation in the anterior Cingulate cortex and parietal operculum/posterior Insula: an event-related functional magnetic resonance imaging study. J Neurosci. 2000;20(19):7438–7445.
    1. Koyama T, McHaffie JG, Laurienti PJ, Coghill RC. The subjective experience of pain: where expectations become reality. Proc Natl Acad Sci U S A. 2005;102(36):12950–12955. doi: 10.1073/pnas.0408576102.
    1. Keltner JR, Furst A, Fan C, Redfern R, Inglis B, Fields HL. Isolating the modulatory effect of expectation on pain transmission: a functional magnetic resonance imaging study. J Neurosci. 2006;26(16):4437–4443. doi: 10.1523/JNEUROSCI.4463-05.2006.
    1. Kong J, Gollub RL, Polich G, Kirsch I, Laviolette P, Vangel M, Rosen B, Kaptchuk TJ. A functional magnetic resonance imaging study on the neural mechanisms of hyperalgesic nocebo effect. J Neurosci. 2008;28(49):13354–13362. doi: 10.1523/JNEUROSCI.2944-08.2008.
    1. Wager TD, Matre D, Casey KL. Placebo effects in laser-evoked pain potentials. Brain Behav Immun. 2006;20(3):219–230. doi: 10.1016/j.bbi.2006.01.007.
    1. Piedimonte A, Guerra G, Vighetti S, Carlino E. Measuring expectation of pain: contingent negative variation in placebo and nocebo effects. Eur J Pain. 2017;21(5):874–885. doi: 10.1002/ejp.990.
    1. Carlino E, Torta DM, Piedimonte A, Frisaldi E, Vighetti S, Benedetti F. Role of explicit verbal information in conditioned analgesia. Eur J Pain. 2015;19(4):546–553. doi: 10.1002/ejp.579.
    1. Colloca L, Tinazzi M, Recchia S, Le Pera D, Fiaschi A, Benedetti F, Valeriani M. Learning potentiates neurophysiological and behavioral placebo analgesic responses. Pain. 2008;139(2):306–314. doi: 10.1016/j.pain.2008.04.021.
    1. Benedetti F, Pollo A, Lopiano L, Lanotte M, Vighetti S, Rainero I. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci. 2003;23(10):4315–4323.
    1. Levine JD, Gordon NC, Fields HL. The mechanism of placebo analgesia. Lancet. 1978;2(8091):654–657. doi: 10.1016/S0140-6736(78)92762-9.
    1. Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci. 1999;19(1):484–494.
    1. Benedetti F, Amanzio M, Maggi G. Potentiation of placebo analgesia by proglumide. Lancet. 1995;346(8984):1231. doi: 10.1016/S0140-6736(95)92938-X.
    1. Benedetti F. The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. Pain. 1996;64(3):535–543. doi: 10.1016/0304-3959(95)00179-4.
    1. Benedetti F, Amanzio M, Thoen W. Disruption of opioid-induced placebo responses by activation of cholecystokinin type-2 receptors. Psychopharmacology. 2011;213(4):791–797. doi: 10.1007/s00213-010-2037-y.
    1. Benedetti F, Amanzio M, Rosato R, Blanchard C. Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nat Med. 2011;17(10):1228–1230. doi: 10.1038/nm.2435.
    1. Zubieta JK, Bueller JA, Jackson LR, Scott DJ, Xu Y, Koeppe RA, Nichols TE, Stohler CS. Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J Neurosci. 2005;25(34):7754–7762. doi: 10.1523/JNEUROSCI.0439-05.2005.
    1. Wager TD, Scott DJ, Zubieta JK. Placebo effects on human mu-opioid activity during pain. Proc Natl Acad Sci U S A. 2007;104(26):11056–11061. doi: 10.1073/pnas.0702413104.
    1. Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK. Individual differences in reward responding explain placebo-induced expectations and effects. Neuron. 2007;55(2):325–336. doi: 10.1016/j.neuron.2007.06.028.
    1. Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry. 2008;65(2):220–231. doi: 10.1001/archgenpsychiatry.2007.34.
    1. Kessner S, Sprenger C, Wrobel N, Wiech K, Bingel U. Effect of oxytocin on placebo analgesia: a randomized study. JAMA. 2013;310(16):1733–1735. doi: 10.1001/jama.2013.277446.
    1. Colloca L, Pine DS, Ernst M, Miller FG, Grillon C. Vasopressin boosts placebo analgesic effects in women: a randomized trial. Biol Psychiatry. 2016;79(10):794–802. doi: 10.1016/j.biopsych.2015.07.019.
    1. Benedetti F, Durando J, Vighetti S. Nocebo and placebo modulation of hypobaric hypoxia headache involves the cyclooxygenase-prostaglandins pathway. Pain. 2014;155(5):921–928. doi: 10.1016/j.pain.2014.01.016.
    1. Bishop MD, Bialosky JE, Cleland JA. Patient expectations of benefit from common interventions for low back pain and effects on outcome: secondary analysis of a clinical trial of manual therapy interventions. J. Man Manip Ther. 2011;19(1):20–25. doi: 10.1179/106698110X12804993426929.
    1. Ferreira PH, Ferreira ML, Maher CG, Refshauge KM, Latimer J, Adams RD. The therapeutic alliance between clinicians and patients predicts outcome in chronic low back pain. Phys Ther. 2013;93(4):470–478. doi: 10.2522/ptj.20120137.
    1. Fuentes J, Armijo-Olivo S, Funabashi M, Miciak M, Dick B, Warren S, Rashiq S, Magee DJ, Gross DP. Enhanced therapeutic alliance modulates pain intensity and muscle pain sensitivity in patients with chronic low back pain: an experimental controlled study. Phys Ther. 2014;94(4):477–489. doi: 10.2522/ptj.20130118.
    1. Wand BM, Tulloch VM, George PJ, Smith AJ, Goucke R, O'Connell NE, Moseley GL. Seeing it helps: movement-related back pain is reduced by visualization of the back during movement. Clin J Pain. 2012;28(7):602–608. doi: 10.1097/AJP.0b013e31823d480c.
    1. Myers SS, Phillips RS, Davis RB, Cherkin DC, Legedza A, Kaptchuk TJ, Hrbek A, Buring JE, Post D, Connelly MT, et al. Patient expectations as predictors of outcome in patients with acute low back pain. J Gen Intern Med. 2008;23(2):148–153. doi: 10.1007/s11606-007-0460-5.
    1. Linde K, Witt CM, Streng A, Weidenhammer W, Wagenpfeil S, Brinkhaus B, Willich SN, Melchart D. The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain. 2007;128(3):264–271. doi: 10.1016/j.pain.2006.12.006.
    1. Kalauokalani D, Cherkin DC, Sherman KJ, Koepsell TD, Deyo RA. Lessons from a trial of acupuncture and massage for low back pain: patient expectations and treatment effects. Spine (Phila Pa 1976) 2001;26(13):1418–1424. doi: 10.1097/00007632-200107010-00005.
    1. Sherman KJ, Cherkin DC, Ichikawa L, Avins AL, Delaney K, Barlow WE, Khalsa PS, Deyo RA. Treatment expectations and preferences as predictors of outcome of acupuncture for chronic back pain. Spine (Phila Pa 1976) 2010;35(15):1471–1477. doi: 10.1097/BRS.0b013e3181c2a8d3.
    1. George SZ, Robinson ME. Preference, expectation, and satisfaction in a clinical trial of behavioral interventions for acute and sub-acute low back pain. J Pain. 2010;11(11):1074–1082. doi: 10.1016/j.jpain.2010.02.016.
    1. Skatteboe S, Roe C, Fagerland MW, Granan LP. Expectations of pain and functioning in patients with musculoskeletal disorders: a cross-sectional study. BMC Musculoskelet Disord. 2017;18(1):48. doi: 10.1186/s12891-016-1386-z.
    1. Kongsted A, Vach W, Axo M, Bech RN, Hestbaek L. Expectation of recovery from low back pain: a longitudinal cohort study investigating patient characteristics related to expectations and the association between expectations and 3-month outcome. Spine (Phila Pa 1976) 2014;39(1):81–90. doi: 10.1097/BRS.0000000000000059.
    1. Goossens ME, Vlaeyen JW, Hidding A, Kole-Snijders A, Evers SM. Treatment expectancy affects the outcome of cognitive-behavioral interventions in chronic pain. Clin J Pain. 2005;21:18–26. doi: 10.1097/00002508-200501000-00003.
    1. Wasan AD, Kong J, Pham LD, Kaptchuk TJ, Edwards R, Gollub RL. The impact of placebo, psychopathology, and expectations on the response to acupuncture needling in patients with chronic low back pain. J Pain. 2010;11(6):555–563. doi: 10.1016/j.jpain.2009.09.013.
    1. Witt CM, Schützler L, Lüdtke R, Wegscheider K, Willich SN. Patient characteristics and variation in treatment outcomes: which patients benefit most from acupuncture for chronic pain? Clin J Pain. 2011;27(6):550–555. doi: 10.1097/AJP.0b013e31820dfbf5.
    1. Vase L, Vollert J, Finnerup NB, Miao X, Atkinson G, Marshall S, Nemeth R, Lange B, Liss C, Price DD, et al. Predictors of the placebo analgesia response in randomized controlled trials of chronic pain: a meta-analysis of the individual data from nine industrially sponsored trials. Pain. 2015;156(9):1795–1802. doi: 10.1097/j.pain.0000000000000217.
    1. Graz B, Wietlisbach V, Porchet F, Vader JP. Prognosis or “curabo effect?”: physician prediction and patient outcome of surgery for low back pain and sciatica. Spine (Phila Pa 1976) 2005;30(12):1448–1452. doi: 10.1097/01.brs.0000166508.88846.b3.
    1. Darlow B, Fullen BM, Dean S, Hurley DA, Baxter GD, Dowell A. The association between health care professional attitudes and beliefs and the attitudes and beliefs, clinical management, and outcomes of patients with low back pain: a systematic review. Eur J Pain. 2012;16(1):3–17. doi: 10.1016/j.ejpain.2011.06.006.
    1. Sit RW, Yip BH, Chan DC, Wong SY. Primary care physicians’ attitudes and beliefs towards chronic low back pain: an Asian study. PLoS One. 2015;10(1):e0117521. doi: 10.1371/journal.pone.0117521.
    1. Farin E, Gramm L, Schmidt E. The patient-physician relationship in patients with chronic low back pain as a predictor of outcomes after rehabilitation. J Behav Med. 2013;36(3):246–258. doi: 10.1007/s10865-012-9419-z.
    1. Zangrando F, Piccinini G, Tagliolini C, Marsilli G, Iosa M, Vulpiani MC, Paolucci T. The efficacy of a preparatory phase of a touch-based approach in treating chronic low back pain: a randomized controlled trial. J Pain Res. 2017;10:941–949. doi: 10.2147/JPR.S129313.
    1. Gardner T, Refshauge K, McAuley J, Goodall S, Hubscher M, Smith L. Patient-led goal setting: a pilot study investigating a promising approach for the Management of Chronic low Back Pain. Spine (Phila Pa 1976) 2016;41(18):1405–1413. doi: 10.1097/BRS.0000000000001545.
    1. Gardner T, Refshauge K, Smith L, McAuley J, Hubscher M, Goodall S. Physiotherapists’ beliefs and attitudes influence clinical practice in chronic low back pain: a systematic review of quantitative and qualitative studies. J Phys. 2017;63(3):132–143.
    1. Louw A, Zimne K, Landers MR, Luttrell M, Clair B, Mills J. A randomised controlled trial of ‘clockwise’ ultrasound for low back pain. South African J Physiotherapy. 2016;72(1):1–7. doi: 10.4102/sajp.v72i1.306.
    1. Bishop MD, Mintken PE, Bialosky JE, Cleland JA. Patient expectations of benefit from interventions for neck pain and resulting influence on outcomes. J Orthop Sports Phys Ther. 2013;43(7):457–465. doi: 10.2519/jospt.2013.4492.
    1. Diers M, Zieglgansberger W, Trojan J, Drevensek AM, Erhardt-Raum G, Flor H. Site-specific visual feedback reduces pain perception. Pain. 2013;154(6):890–896. doi: 10.1016/j.pain.2013.02.022.
    1. Groeneweg R, Haanstra T, Bolman CAW, Oostendorp RAB, van Tulder MW, Ostelo R. Treatment success in neck pain: the added predictive value of psychosocial variables in addition to clinical variables. Scand J Pain. 2017;14:44–52. doi: 10.1016/j.sjpain.2016.10.003.
    1. Chester R, Jerosch-Herold C, Lewis J, Shepstone L. Psychological factors are associated with the outcome of physiotherapy for people with shoulder pain: a multicentre longitudinal cohort study. Br J Sports Med. 2016.[Epub ahead of print]
    1. Louw A, Puentedura EJ, Reese D, Parker P, Miller T, Mintken PE. Immediate effects of mirror therapy in patients with shoulder pain and decreased range of motion. Arch Phys Med Rehabil. 2017;98(10):1941–1947. doi: 10.1016/j.apmr.2017.03.031.
    1. Abhishek A, Doherty M. Mechanisms of the placebo response in pain in osteoarthritis. Osteoarthr Cartil. 2013;21(9):1229–1235. doi: 10.1016/j.joca.2013.04.018.
    1. Doherty M, Dieppe P. The “placebo” response in osteoarthritis and its implications for clinical practice. Osteoarthr Cartil. 2009;17(10):1255–1262. doi: 10.1016/j.joca.2009.03.023.
    1. Zou K, Wong J, Abdullah N, Chen X, Smith T, Doherty M, Zhang W. Examination of overall treatment effect and the proportion attributable to contextual effect in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis. 2016;75(11):1964–1970. doi: 10.1136/annrheumdis-2015-208387.
    1. Coste J, Montel S. Placebo-related effects: a meta-narrative review of conceptualization, mechanisms and their relevance in rheumatology. Rheumatology (Oxford) 2017;56(3):334–343.
    1. Zhang W, Robertson J, Jones AC, Dieppe PA, Doherty M. The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis. 2008;67(12):1716–1723. doi: 10.1136/ard.2008.092015.
    1. Bannuru RR, McAlindon TE, Sullivan MC, Wong JB, Kent DM, Schmid CH. Effectiveness and implications of alternative placebo treatments: a systematic review and network meta-analysis of osteoarthritis trials. Ann Intern Med. 2015;163(5):365–372. doi: 10.7326/M15-0623.
    1. White P, Bishop FL, Prescott P, Scott C, Little P, Lewith G. Practice, practitioner, or placebo? A multifactorial, mixed-methods randomized controlled trial of acupuncture. Pain. 2012;153(2):455–462. doi: 10.1016/j.pain.2011.11.007.
    1. Suarez-Almazor ME, Looney C, Liu Y, Cox V, Pietz K, Marcus DM, Street RL., Jr A randomized controlled trial of acupuncture for osteoarthritis of the knee: effects of patient-provider communication. Arthritis Care Res. 2010;62(9):1229–1236. doi: 10.1002/acr.20225.
    1. Street RL, Jr, Cox V, Kallen MA, Suarez-Almazor ME. Exploring communication pathways to better health: clinician communication of expectations for acupuncture effectiveness. Patient Educ Couns. 2012;89(2):245–251. doi: 10.1016/j.pec.2012.06.032.
    1. Lu DF, Hart LK, Lutgendorf SK, Perkhounkova Y. The effect of healing touch on the pain and mobility of persons with osteoarthritis: a feasibility study. Geriatr Nurs. 2013;34(4):314–322. doi: 10.1016/j.gerinurse.2013.05.003.
    1. Forward JB, Greuter NE, Crisall SJ, Lester HF. Effect of structured touch and guided imagery for pain and anxiety in elective joint replacement patients--a randomized controlled trial: M-TIJRP. Pers J. 2015;19(4):18–28.
    1. Shankland B, Beaton D, Ahmed S, Nedelec B. Effects of client-centered multimodal treatment on impairment, function, and satisfaction of people with thumb carpometacarpal osteoarthritis. J Hand Ther. 2017;
    1. Nestoriuc Y, Orav EJ, Liang MH, Horne R, Barsky AJ. Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines. Arthritis Care Res. 2010;62(6):791–799. doi: 10.1002/acr.20160.
    1. Fors EA, Landmark T, Bakke Ø. Contextual and time dependent pain in fibromyalgia: an explorative study. BMC Res Notes. 2012;20(5):644. doi: 10.1186/1756-0500-5-644.
    1. Chen X, Zou K, Abdullah N, Whiteside N, Sarmanova A, Doherty M, Zhang W. The placebo effect and its determinants in fibromyalgia: meta-analysis of randomised controlled trials. Clin Rheumatol. 2017;36(7):1623–1630. doi: 10.1007/s10067-017-3595-8.
    1. Hauser W, Bartram-Wunn E, Bartram C, Reinecke H, Tolle T. Systematic review: placebo response in drug trials of fibromyalgia syndrome and painful peripheral diabetic neuropathy-magnitude and patient-related predictors. Pain. 2011;152(8):1709–1717. doi: 10.1016/j.pain.2011.01.050.
    1. Mitsikostas DD, Chalarakis NG, Mantonakis LI, Delicha EM, Sfikakis PP. Nocebo in fibromyalgia: meta-analysis of placebo-controlled clinical trials and implications for practice. Eur J Neurol. 2012;19(5):672–680. doi: 10.1111/j.1468-1331.2011.03528.x.
    1. Denison B. Touch the pain away: new research on therapeutic touch and persons with fibromyalgia syndrome. Holist Nurs Pract. 2004;18(3):142–151. doi: 10.1097/00004650-200405000-00006.
    1. Kosek E, Rosen A, Carville S, Choy E, Gracely RH, Marcus H, Petzke F, Ingvar M, Jensen KB. Lower placebo responses after long-term exposure to fibromyalgia pain. J Pain. 2017;18(7):835–843. doi: 10.1016/j.jpain.2017.02.434.
    1. Berthelot JM. The placebo effect in rheumatology: new data. Joint Bone Spine. 2011;78(2):161–165. doi: 10.1016/j.jbspin.2010.08.006.
    1. Häuser W, Bartram C, Bartram-Wunn E, Tölle T. Adverse events attributable to nocebo in randomized controlled drug trials in fibromyalgia syndrome and painful diabetic peripheral neuropathy: systematic review. Clin J Pain. 2012;28(5):437–451. doi: 10.1097/AJP.0b013e3182321ad8.
    1. Koog YH, Lee JS, Wi H. Nonspecific adverse events in knee osteoarthritis clinical trials: a systematic review. PLoS One. 2014;9(11):e111776. doi: 10.1371/journal.pone.0111776.
    1. Reiter-Niesert S, Boers M, Detert J. Short-term placebo response in trials of patients with symptomatic osteoarthritis: differences between hip and knee. Osteoarthr Cartil. 2016;24(6):1007–1011. doi: 10.1016/j.joca.2016.01.002.
    1. Zhang W, Doherty M. Efficacy paradox and proportional contextual effect (PCE) Clin Immunol. 2017;17:30539.
    1. Puhl AA, Reinhart CJ, Rok ER, Injeyan HS. An examination of the observed placebo effect associated with the treatment of low back pain - a systematic review. Pain Res Manag. 2011;16(1):45–52. doi: 10.1155/2011/625315.
    1. Menke JM. Do manual therapies help low back pain? A comparative effectiveness meta-analysis. Spine (Phila Pa 1976) 2014;39(7):E463–E472. doi: 10.1097/BRS.0000000000000230.
    1. Auer CJ, Glombiewski JA, Doering BK, Winkler A, Laferton JA, Broadbent E, Rief W. Patients’ expectations predict surgery outcomes: a meta-analysis. Int J Behav Med. 2016;23(1):49–62. doi: 10.1007/s12529-015-9500-4.
    1. Muller M, Kamping S, Benrath J, Skowronek H, Schmitz J, Klinger R, Flor H. Treatment history and placebo responses to experimental and clinical pain in chronic pain patients. Eur J Pain. 2016;20(9):1530–1541. doi: 10.1002/ejp.877.
    1. Birkhauer J, Gaab J, Kossowsky J, Hasler S, Krummenacher P, Werner C, Gerger H. Trust in the health care professional and health outcome: a meta-analysis. PLoS One. 2017;12(2):e0170988. doi: 10.1371/journal.pone.0170988.
    1. Linton SJ, Vlaeyen J, Ostelo R. The back pain beliefs of health care providers: are we fear-avoidant? J Occup Rehabil. 2002;12(4):223–232. doi: 10.1023/A:1020218422974.
    1. Witt CM, Martins F, Willich SN, Schutzler L. Can I help you? Physicians’ expectations as predictor for treatment outcome. Eur J Pain. 2012;16(10):1455–1466. doi: 10.1002/j.1532-2149.2012.00152.x.
    1. Mistiaen P, van Osch M, van Vliet L, Howick J, Bishop FL, Di Blasi Z, Bensing J, van Dulmen S. The effect of patient-practitioner communication on pain: a systematic review. Eur J Pain. 2016;20(5):675–688. doi: 10.1002/ejp.797.
    1. Peerdeman KJ, van Laarhoven AI, Keij SM, Vase L, Rovers MM, Peters ML, Evers AW. Relieving patients’ pain with expectation interventions: a meta-analysis. Pain. 2016;157(6):1179–1191. doi: 10.1097/j.pain.0000000000000540.
    1. Decker S, Wardell DW, Cron SG. Using a healing touch intervention in older adults with persistent pain: a feasibility study. J Holist Nurs. 2012;30(3):205–213. doi: 10.1177/0898010112440884.
    1. Wardell DW, Decker SA, Engebretson JC. Healing touch for older adults with persistent pain. Holist Nurs Pract. 2012;26(4):194–202. doi: 10.1097/HNP.0b013e318258528d.
    1. Dibbelt S, Schaidhammer M, Fleischer C, Greitemann B. Patient-doctor interaction in rehabilitation: the relationship between perceived interaction quality and long-term treatment results. Patient Educ Couns. 2009;76(3):328–335. doi: 10.1016/j.pec.2009.07.031.
    1. Kelley JM, Kraft-Todd G, Schapira L, Kossowsky J, Riess H. The influence of the patient-clinician relationship on healthcare outcomes: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2014;9(4):e94207. doi: 10.1371/journal.pone.0094207.
    1. Yakunchikov DY, Olechowski CJ, Simmonds MK, Verrier MJ, Rashiq S, McWilliams LA, Sobolev IA, Dick BD. The effect of social observational learning, empathy and Catastrophizing in chronic pain patients during acute pain induction. Pain Med. 2017;18(5):871–878.
    1. Goubert L, Vlaeyen JW, Crombez G, Craig KD. Learning about pain from others: an observational learning account. J. Pain. 2011;12(2):167–174. doi: 10.1016/j.jpain.2010.10.001.
    1. Jonas WB, Crawford C, Colloca L, Kaptchuk TJ, Moseley B, Miller FG, Kriston L, Linde K, Meissner K. To what extent are surgery and invasive procedures effective beyond a placebo response? A systematic review with meta-analysis of randomised, sham controlled trials. BMJ Open. 2015;5(12):e009655. doi: 10.1136/bmjopen-2015-009655.
    1. Gu AP, Gu CN, Ahmed AT, Murad MH, Wang Z, Kallmes DF, Brinjikji W. Sham surgical procedures for pain intervention result in significant improvements in pain: systematic review and meta-analysis. J Clin Epidemiol. 2017;83:18–23. doi: 10.1016/j.jclinepi.2016.12.010.
    1. Laursen J, Danielsen A, Rosenberg J. Effects of environmental design on patient outcome: a systematic review. Health Environ Res Des J. 2014;7(4):108–119.
    1. Iyendo TO. Uwajeh PC, Ikenna ES. The therapeutic impacts of environmental design interventions on wellness in clinical settings: a narrative review. Complement Ther Clin Pract. 2016;24:174–188. doi: 10.1016/j.ctcp.2016.06.008.
    1. Iyendo TO Exploring the effect of sound and music on health in hospital settings: a narrative review. Int J Nurs Stud. 2016;63:82–100. doi: 10.1016/j.ijnurstu.2016.08.008.
    1. Nijs J, Roussel N, Paul van Wilgen C, Koke A, Smeets R. Thinking beyond muscles and joints: therapists’ and patients’ attitudes and beliefs regarding chronic musculoskeletal pain are key to applying effective treatment. Man Ther. 2013;18(2):96–102. doi: 10.1016/j.math.2012.11.001.
    1. Edwards I, Richardson B. Clinical reasoning and population health: decision making for an emerging paradigm of health care. Physiother Theory Pract. 2008;24(3):183–193. doi: 10.1080/09593980701593797.
    1. De Felice M, Ossipov MH. Cortical and subcortical modulation of pain. Pain Manag. 2016;6(2):111–120. doi: 10.2217/pmt.15.63.
    1. Vase L, JLr R, Price DD. A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain. 2002;99(3):443–452. doi: 10.1016/S0304-3959(02)00205-1.
    1. Vase L, Petersen GL, Riley JL, 3rd, Price DD. Factors contributing to large analgesic effects in placebo mechanism studies conducted between 2002 and 2007. Pain. 2009;145(1-2):36–44. doi: 10.1016/j.pain.2009.04.008.
    1. Price DD, Riley JL, 3rd, Vase L. Reliable differences in placebo effects between clinical analgesic trials and studies of placebo analgesia mechanisms. Pain. 2003;104:715–716. doi: 10.1016/S0304-3959(03)00165-9.
    1. Petersen GL, Finnerup NB, Colloca L, Amanzio M, Price DD, Jensen TS, Vase L. The magnitude of nocebo effects in pain: a meta-analysis. Pain. 2014;155(8):1426–1434. doi: 10.1016/j.pain.2014.04.016.
    1. Hróbjartsson A, Gøtzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med. 2001;344(21):1594–1602. doi: 10.1056/NEJM200105243442106.
    1. Hróbjartsson A, Gøtzsche PC. Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment. J Intern Med. 2004;256(2):91–100. doi: 10.1111/j.1365-2796.2004.01355.x.
    1. Hróbjartsson A, Gøtzsche PC. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev. 2010;20(1):CD003974.
    1. Klinger R, Flor H. Clinical and ethical implications of placebo effects: enhancing patients’ benefits from pain treatment. Handb Exp Pharmacol. 2014;225:217–235. doi: 10.1007/978-3-662-44519-8_13.
    1. Bishop FL, Coghlan B, Geraghty AW, Everitt H, Little P, Holmes MM, Seretis D, Lewith G. What techniques might be used to harness placebo effects in non-malignant pain? A literature review and survey to develop a taxonomy. BMJ Open. 2017;7(6):e015516. doi: 10.1136/bmjopen-2016-015516.
    1. Colloca L, Grillon C. Understanding placebo and nocebo responses for pain management. Curr Pain Headache Rep. 2014;18(6):419. doi: 10.1007/s11916-014-0419-2.
    1. Carlino E, Pollo A, Benedetti F. The placebo in practice: how to use it in clinical routine. Curr Opin Support Palliat Care. 2012;6(2):220–225. doi: 10.1097/SPC.0b013e32835269c1.
    1. Klinger R, Colloca L, Bingel U, Flor H. Placebo analgesia: clinical applications. Pain. 2014;155(6):1055–1058. doi: 10.1016/j.pain.2013.12.007.
    1. Klinger R, Blasini M, Schmitz J, Colloca L. Nocebo effects in clinical studies: hints for pain therapy. Pain Rep. 2017;2(2):e586. doi: 10.1097/PR9.0000000000000586.
    1. Rief W, Shedden-Mora MC, Laferton JA, Auer C, Petrie KJ, Salzmann S, Schedlowski M, Moosdorf R. Preoperative optimization of patient expectations improves long-term outcome in heart surgery patients: results of the randomized controlled PSY-HEART trial. BMC Med. 2017;15(1):4. doi: 10.1186/s12916-016-0767-3.
    1. Younger J, Gandhi V, Hubbard E, Mackey S. Development of the Stanford expectations of treatment scale (SETS): a tool for measuring patient outcome expectancy in clinical trials. Clin Trials. 2012;9(6):767–776. doi: 10.1177/1740774512465064.
    1. Bingel U. Avoiding nocebo effects to optimize treatment outcome. JAMA. 2014;312(7):693–694. doi: 10.1001/jama.2014.8342.
    1. Amanzio M, Palermo S, Skyt I, Vase L. Lessons learned from Nocebo effects in clinical trials for pain conditions and neurodegenerative disorders. J Clin Psychopharmacol. 2016;36(5):475–482. doi: 10.1097/JCP.0000000000000556.
    1. Wertli MM, Held U, Lis A, Campello M, Weiser S. Both positive and negative beliefs are important in patients with spine pain: findings from the Occupational and Industrial Orthopaedic Center registry. Spine J. 2017. [Epub ahead of print]
    1. Schenk L, Krimmel SR, Colloca L. Observe to get pain relief: current evidence and potential mechanisms of socially learned pain modulation. Pain. 2017;158(11):2077–2081. doi: 10.1097/j.pain.0000000000000943.
    1. Koban L, Jepma M, Geuter S, Wager TD. What's in a word? How instructions, suggestions, and social information change pain and emotion. Neurosci Biobehav Rev. 2017;81(Pt A):29–42. doi: 10.1016/j.neubiorev.2017.02.014.
    1. Benedetti F, Amanzio M. The placebo response: how words and rituals change the patient's brain. Patient Educ Couns. 2011;84(3):413–419. doi: 10.1016/j.pec.2011.04.034.
    1. Benedetti F. Placebo-induced improvements: how therapeutic rituals affect the patient's brain. J Acupunct Meridian Stud. 2012;5(3):97–103. doi: 10.1016/j.jams.2012.03.001.
    1. Webster RK, Weinman J, Rubin GJ. A systematic review of factors that contribute to nocebo effects. Health Psychol. 2016;35(12):1334–1355. doi: 10.1037/hea0000416.
    1. Booth J, Moseley GL, Schiltenwolf M, Cashin A, Davies M, Hubscher M. Exercise for chronic musculoskeletal pain: a biopsychosocial approach. Musculoskeletal care. 2017;15(4):413–421. doi: 10.1002/msc.1191.
    1. Wijma AJ, Bletterman AN, Clark JR, Vervoort S, Beetsma A, Keizer D, Nijs J, Van Wilgen CP. Patient-centeredness in physiotherapy: what does it entail? A systematic review of qualitative studies. Physiother Theory Pract. 2017;33(11):825–840. doi: 10.1080/09593985.2017.1357151.
    1. Stevens A, Koke A, van der Weijden T, Beurskens A. The development of a patient-specific method for physiotherapy goal setting: a user-centered design. Disabil Rehabil. 2017; 13:1-8. [Epub ahead of print]
    1. Liu T. Route of placebo administration: robust placebo effects in laboratory and clinical settings. Neurosci Biobehav Rev. 2017;83:451–457. doi: 10.1016/j.neubiorev.2017.09.018.
    1. Howick J, Rees S. Overthrowing barriers to empathy in healthcare: empathy in the age of the internet. J R Soc Med. 2017;110(9):352–357. doi: 10.1177/0141076817714443.
    1. Henry SG, Bell RA, Fenton JJ, Kravitz RL. Communication about chronic pain and opioids in primary care: Impact on patient and physician visit experience. Pain. 2017. [Epub ahead of print]
    1. Babatunde F, MacDermid J, MacIntyre N. Characteristics of therapeutic alliance in musculoskeletal physiotherapy and occupational therapy practice: a scoping review of the literature. BMC Health Serv Res. 2017;17(1):375. doi: 10.1186/s12913-017-2311-3.
    1. Colloca L, Finniss D. Nocebo effects, patient-clinician communication, and therapeutic outcomes. JAMA. 2012;307(6):567–568. doi: 10.1001/jama.2012.115.
    1. Howick J, Lewith G, Mebius A, Fanshawe TR, Bishop F, van Osch M, van Dulmen S, Christelis N, Kaptchuk T, Mistiaen P. Positive messages may reduce patient pain: a meta-analysis. Eur J Intern Med. 2017;11:31–38. doi: 10.1016/j.eujim.2017.03.005.
    1. Fassler M, Meissner K, Schneider A, Linde K. Frequency and circumstances of placebo use in clinical practice--a systematic review of empirical studies. BMC Med. 2010;8:15. doi: 10.1186/1741-7015-8-15.
    1. Baldwin MJ, Wartolowska K, Carr AJ. A survey on beliefs and attitudes of trainee surgeons towards placebo. BMC Surg. 2016;16(1):27. doi: 10.1186/s12893-016-0142-5.
    1. Wartolowska K, Beard DJ, Carr AJ. Attitudes and beliefs about placebo surgery among orthopedic shoulder surgeons in the United Kingdom. PLoS One. 2014;9(3):e91699. doi: 10.1371/journal.pone.0091699.
    1. Berthelot JM, Maugars Y, Abgrall M, Prost A. Interindividual variations in beliefs about the placebo effect: a study in 300 rheumatology inpatients and 100 nurses. Joint Bone Spine. 2001;68(1):65–70. doi: 10.1016/S1297-319X(00)00225-6.
    1. Kisaalita N, Staud R, Hurley R, Robinson M. Placebo use in pain management: the role of medical context, treatment efficacy, and deception in determining placebo acceptability. Pain. 2014;155(12):2638–2645. doi: 10.1016/j.pain.2014.09.029.
    1. Hughes J, Greville-Harris M, Graham CA, Lewith G, White P, Bishop FL. What trial participants need to be told about placebo effects to give informed consent: a survey to establish existing knowledge among patients with back pain. J Med Ethics. 2017;43(12):867–870. doi: 10.1136/medethics-2016-103964.
    1. Miller FG, Colloca L. The placebo phenomenon and medical ethics: rethinking the relationship between informed consent and risk-benefit assessment. Theor Med Bioeth. 2011;32(4):229–243. doi: 10.1007/s11017-011-9179-8.
    1. Miller FG, Colloca L. The legitimacy of placebo treatments in clinical practice: evidence and ethics. Am J Bioeth. 2009;9(12):39–47. doi: 10.1080/15265160903316263.
    1. Blease C, Colloca L, Kaptchuk TJ. Are open-label placebos ethical? Informed consent and ethical equivocations. Bioethics. 2016;30(6):407–414. doi: 10.1111/bioe.12245.
    1. Alfano M. Placebo effects and informed consent. Am J Bioeth. 2015;15(10):3–12. doi: 10.1080/15265161.2015.1074302.
    1. Charlesworth JEG, Petkovic G, Kelley JM, Hunter M, Onakpoya I, Roberts N, Miller FG, Howick J. Effects of placebos without deception compared with no treatment: a systematic review and meta-analysis. J Evid Based Med. 2017;10(2):97–107. doi: 10.1111/jebm.12251.
    1. Annoni M, Miller FG. Placebo effects and the ethics of therapeutic communication: a pragmatic perspective. Kennedy Inst Ethics J. 2016;26(1):79–103. doi: 10.1353/ken.2016.0004.
    1. Carvalho C, Caetano JM, Cunha L, Rebouta P, Kaptchuk TJ, Kirsch I. Open-label placebo treatment in chronic low back pain: a randomized controlled trial. Pain. 2016;157(12):2766–2772. doi: 10.1097/j.pain.0000000000000700.
    1. Bialosky JE, Robinson ME. Placebo disclosure does not result in negative changes in mood or attitudes towards health care or the provider. J Man Manip Ther. 2017;25(3):151–159. doi: 10.1080/10669817.2017.1298699.
    1. Benedetti F, Carlino E, Piedimonte A. Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Hawthorne effects. Lancet Neurol. 2016;15(7):736–747. doi: 10.1016/S1474-4422(16)00066-1.
    1. Colloca L, Miller FG. Harnessing the placebo effect: the need for translational research. Philos Trans R Soc Lond Ser B Biol Sci. 2011;366(1572):1922–1930. doi: 10.1098/rstb.2010.0399.
    1. Linde K, Fassler M, Meissner K. Placebo interventions, placebo effects and clinical practice. Philos Trans R Soc Lond Ser B Biol Sci. 2011;366(1572):1905–1912. doi: 10.1098/rstb.2010.0383.
    1. Rossettini G, Testa M. Manual therapy RCTs: should we control placebo in placebo control? Eur. J Phys Rehabil Med. 2017. [Epub ahead of print]
    1. Puhl AA, Reinhart CJ, Doan JB, Vernon H. The quality of placebos used in randomized, controlled trials of lumbar and pelvic joint thrust manipulation-a systematic review. Spine J. 2017;17(3):445–456. doi: 10.1016/j.spinee.2016.11.003.
    1. Cerritelli F, Verzella M, Cicchitti L, D'Alessandro G, Vanacore N. The paradox of sham therapy and placebo effect in osteopathy: a systematic review. Medicine. 2016;95(35):e4728. doi: 10.1097/MD.0000000000004728.
    1. Maddocks M, Kerry R, Turner A, Howick J. Problematic placebos in physical therapy trials. J Eval Clin Pract. 2016;22(4):598–602. doi: 10.1111/jep.12582.
    1. Frisaldi E, Shaibani A, Benedetti F. Why we should assess Patients’ expectations in clinical trials. Pain Ther. 2017;6(1):107–110. doi: 10.1007/s40122-017-0071-8.
    1. Peerdeman KJ, van Laarhoven AI, Peters ML, Evers AW. An integrative review of the influence of expectancies on pain. Front Psychol. 2016;7:1270. doi: 10.3389/fpsyg.2016.01270.
    1. Laferton JA, Kube T, Salzmann S, Auer CJ, Shedden-Mora MC. Patients’ expectations regarding medical treatment: a critical review of concepts and their assessment. Front Psychol. 2017;8:233. doi: 10.3389/fpsyg.2017.00233.
    1. Greco CM, Yu L, Johnston KL, Dodds NE, Morone NE, Glick RM, Schneider MJ, Klem ML, McFarland CE, Lawrence S, et al. Measuring nonspecific factors in treatment: item banks that assess the healthcare experience and attitudes from the patient's perspective. Qual Life Res. 2016;25(7):1625–1634. doi: 10.1007/s11136-015-1178-1.
    1. Simmons K, Ortiz R, Kossowsky J, Krummenacher P, Grillon C, Pine D, Colloca L. Pain and placebo in pediatrics: a comprehensive review of laboratory and clinical findings. Pain. 2014;155(11):2229–2235. doi: 10.1016/j.pain.2014.08.036.
    1. Savvas SM, Zelencich LM, Gibson SJ. Should placebo be used routinely for chronic pain in older people? Maturitas. 2014;79(4):389–400. doi: 10.1016/j.maturitas.2014.09.006.
    1. Bingel U, Colloca L, Vase L. Mechanisms and clinical implications of the placebo effect: is there a potential for the elderly? A mini-review. Gerontology. 2011;57(4):354–363. doi: 10.1159/000322090.
    1. Nijs J, Apeldoorn A, Hallegraeff H, Clark J, Smeets R, Malfliet A, Girbes EL, De Kooning M, Ickmans K. Low back pain: guidelines for the clinical classification of predominant neuropathic, nociceptive, or central sensitization pain. Pain Physician. 2015;18(3):E333–E346.
    1. Osani MC, Bannuru RR. What clinicians should know about differential placebo effects. J Comp Eff Res. 2016;5(3):289–296. doi: 10.2217/cer-2015-0005.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner